Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Accumulated Expenses (2019 - 2026)

Praxis Precision Medicines (PRAX) posted Accumulated Expenses of $24.6 million for Q2 2026, up 39.31% on a QoQ basis from $17.6 million in Q1 2026, and up 29.25% year-over-year from $19.0 million in Q2 2025.

Analysis

Praxis Precision Medicines (PRAX) Accumulated Expenses (2019 - 2026) Analysis & Trends

Praxis Precision Medicines has reported Accumulated Expenses for 8 years, with the latest figure at $24.6 million in Q2 2026.

  • On a quarterly basis, Accumulated Expenses rose 29.25% year-over-year to $24.6 million in Q2 2026; TTM through Jun 2026 was $24.6 million, a 29.25% increase from a year earlier, with the FY2025 full-year figure at $35.0 million, up 47.43% from the prior year.
  • Accumulated Expenses was $24.6 million for Q2 2026 at Praxis Precision Medicines, up from $17.6 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $35.0 million in Q4 2025, with the low at $7.0 million in Q1 2024.
  • Average Accumulated Expenses over 5 years is $17.6 million, with a median of $16.7 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Expenses surged 318.75% in 2022, then sank 69.76% in 2023.
  • Over 5 years, Accumulated Expenses stood at $15.8 million in 2022, then plunged by 53.21% to $7.4 million in 2023, then surged by 220.43% to $23.8 million in 2024, then jumped by 47.43% to $35.0 million in 2025, then declined by 29.82% to $24.6 million in 2026.
  • The last three Accumulated Expenses figures came in at $24.6 million (Q2 2026), $17.6 million (Q1 2026), and $35.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.59 Mn
Mar 31, 2026 17.65 Mn
Dec 31, 2025 35.03 Mn
Sep 30, 2025 21.63 Mn
Jun 30, 2025 19.02 Mn
Mar 31, 2025 15.55 Mn
Dec 31, 2024 23.76 Mn
Sep 30, 2024 15.46 Mn
Jun 30, 2024 10.06 Mn
Mar 31, 2024 6.98 Mn
Dec 31, 2023 7.42 Mn
Sep 30, 2023 6.98 Mn
Jun 30, 2023 13.32 Mn
Mar 31, 2023 9.35 Mn
Dec 31, 2022 15.85 Mn
Sep 30, 2022 17.88 Mn
Jun 30, 2022 25.77 Mn
Mar 31, 2022 30.93 Mn
Dec 31, 2021 26.84 Mn
Sep 30, 2021 16.53 Mn
API Access

Praxis Precision Medicines Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PRAX&period=max&api_key=YOUR_API_KEY